|
|
|
|
|
|
|
|
Featured Stories
|
|
1 - 10 of 46
Items
|
|
Tuesday, 24 Jan 2012
Olaf Wendler, London, UK, summarises and comments on one-year outcomes from the SOURCE registry. SOURCE provided procedural results with the commercialised Edwards Sapien valve. [read more]
|
|
|
|
|
|
Tuesday, 13 Dec 2011
Sven Plein, Leeds, UK spoke to Cardiovascular News about the current trends in cardiovascular magnetic resonance (CMR), the benefits of this modality and the recent use of CMR as an endpoint in acute myocardial infarction trials. [read more]
|
|
|
|
|
|
Tuesday, 13 Dec 2011
Amar Krishnaswamy and Murat Tuzcu, Cleveland Clinic, USA, speak on the resurgence of balloon aortic valvuloplasty as a treatment to bridge severely symptomatic patients to transcatheter or surgical aortic valve replacement, or to better understand the contribution of aortic stenosis to functional limitation in patients with multiple comorbidities. [read more]
|
|
|
|
|
|
Friday, 21 Oct 2011
Giuseppe De Luca, Novara, Italy, comments on the results of the DESSERT (Drug-eluting stents in primary angioplasty) cooperation, a meta-analysis of randomised trials which aimed to evaluate the risks and benefits of drug-eluting stents in comparison to bare metal stents in patients undergoing primary percutaneous coronary intervention for STEMI. [read more]
|
|
|
|
|
|
Wednesday, 05 Oct 2011
Roberto M Lang, past president of the American Society of Echocardiography, spoke to Cardiovascular News about the use of 3D echocardiography and the future of the technique. [read more]
|
|
|
|
|
|
Wednesday, 05 Oct 2011
Dean J Kereiakes, USA, comments on the results from the PLATO and TRITON-TIMI 38 trials which randomised patients with acute coronary syndromes to get treatment with either ticagrelor (PLATO) or prasugrel (TRITON-TIMI 38) in comparison to clopidogrel. [read more]
|
|
|
|
|
|
Wednesday, 21 Sep 2011
Run-Lin Gao, described as “the father of interventional cardiology in China” spoke to Cardiovascular News about the Ethica Award recognition, the development of interventional cardiology in China, and the 10th China Interventional Therapeutics (CIT) conference, taking place in Beijing in March 2012. [read more]
|
|
|
|
|
|
Friday, 05 Aug 2011
Deepak L Bhatt, principal investigator of the SYMPLICITY HTN-3, told Cardiovascular News what the principles behind renal denervation are, outcomes from previous trials and the design of the ongoing SYMPLICITY HTN-3 study. [read more]
|
|
|
|
|
|
Friday, 05 Aug 2011
Ralf Lehmann, Frankfurt, Germany, explains how a combination of clinical and anatomical risk factors may provide the optimal predictive model in patients undergoing multivessel percutaneous coronary intervention. [read more]
|
|
|
|
|
|
Tuesday, 12 Jul 2011
Coronary bifurcation lesions make up 15% to 20% of PCIs and remain a challenge for cardiologists due to the complexity of the lesions and the increased frequency of associated adverse events, Marcel Beijk writes to Cardiovascular News. [read more]
|
|
|
|
|
|
Found: 46 Displaying: 1-10
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Latest News |

|
|
|
|
Features |

|
|
|
Profiles |

|
|
|
|